Enviva Inc.
EVA · NYSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1,204,324 | $1,094,276 | $1,041,678 | $875,079 |
| % Growth | 10.1% | 5% | 19% | – |
| Cost of Goods Sold | $1,363,557 | $927,453 | $963,822 | $767,956 |
| Gross Profit | -$159,233 | $166,823 | $77,856 | $107,123 |
| % Margin | -13.2% | 15.2% | 7.5% | 12.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $175,108 | $45,345 |
| SG&A Expenses | $117,179 | $119,713 | $175,108 | $45,345 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $231,458 | $133,990 | $880 | $273 |
| Operating Expenses | $348,637 | $253,703 | $175,108 | $45,345 |
| Operating Income | -$507,870 | -$85,682 | -$97,252 | $61,778 |
| % Margin | -42.2% | -7.8% | -9.3% | 7.1% |
| Other Income/Exp. Net | -$177,982 | -$80,192 | -$64,994 | -$45,725 |
| Pre-Tax Income | -$685,852 | -$165,874 | -$162,246 | $17,149 |
| Tax Expense | -$42 | $2,494 | -$16,975 | $69 |
| Net Income | -$685,994 | -$168,368 | -$145,271 | $17,080 |
| % Margin | -57% | -15.4% | -13.9% | 2% |
| EPS | -9.23 | -2.54 | -2.77 | 0.33 |
| % Growth | -263.4% | 8.3% | -939.4% | – |
| EPS Diluted | -9.23 | -2.51 | -2.77 | 0.33 |
| Weighted Avg Shares Out | 74,447 | 66,312 | 52,407 | 52,407 |
| Weighted Avg Shares Out Dil | 74,447 | 66,966 | 52,407 | 52,407 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $181,987 | $71,585 | $56,497 | $45,996 |
| Depreciation & Amortization | $166,112 | $113,177 | $91,966 | $85,892 |
| EBITDA | -$337,753 | $18,888 | -$13,783 | $22,277 |
| % Margin | -28% | 1.7% | -1.3% | 2.5% |